We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

167 hedge funds and large institutions have $689M invested in Cardiovascular Systems, Inc. in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 12

20% more capital invested

Capital invested by funds: $576M → $689M (+$113M)

18% more funds holding

Funds holding: 142167 (+25)

10% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 50

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

68% less call options, than puts

Call options by funds: $204K | Put options by funds: $631K

Holders
167
Holders Change
+25
Holders Change %
+17.61%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
55
Reduced
50
Closed
12
Calls
$204K
Puts
$631K
Net Calls
-$427K
Net Calls Change
+$36K
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$78.4M +$7.16M +269,425 +11%
BlackRock
2
BlackRock
New York
$66.6M +$62.4M +2,351,115 +61,068%
CCM
3
Camber Capital Management
Massachusetts
$49.5M -$19.9M -750,000 -30%
CIP
4
Champlain Investment Partners
Vermont
$49.3M +$2.36M +89,010 +5%
Vanguard Group
5
Vanguard Group
Pennsylvania
$46.8M +$8.13M +305,953 +23%
CAM
6
Cortina Asset Management
Wisconsin
$24.3M +$22.9M +860,449 New
FCM
7
Frontier Capital Management
Massachusetts
$23.4M -$421K -15,853 -2%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$19.4M -$3.97M -149,416 -18%
State Street
9
State Street
Massachusetts
$19M +$2.22M +83,602 +14%
First Manhattan
10
First Manhattan
New York
$15.1M -$4.63M -174,400 -25%
PHS
11
PFM Health Sciences
California
$12.5M +$232K +8,721 +2%
Northern Trust
12
Northern Trust
Illinois
$11.9M +$133K +5,024 +1%
NCGI
13
Next Century Growth Investors
Minnesota
$10.7M -$7.42M -279,253 -42%
GIM
14
Granahan Investment Management
Massachusetts
$10.2M -$21.1M -794,895 -69%
Millennium Management
15
Millennium Management
New York
$8.82M +$1.58M +59,523 +24%
MWNA
16
Marshall Wace North America
New York
$8.66M +$8.22M +309,411 New
Two Sigma Investments
17
Two Sigma Investments
New York
$8.01M +$1.45M +54,552 +24%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$7.94M +$462K +17,414 +7%
DCM
19
Driehaus Capital Management
Illinois
$7.93M -$953K -35,870 -11%
BCM
20
Brown Capital Management
Maryland
$7.68M +$7.21M +271,470 New
Thrivent Financial for Lutherans
21
Thrivent Financial for Lutherans
Minnesota
$7.41M -$744K -28,000 -10%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$7.4M +$2.71M +101,916 +64%
Invesco
23
Invesco
Georgia
$7.35M +$141K +5,311 +2%
Charles Schwab
24
Charles Schwab
California
$5.66M +$1.85M +69,659 +53%
HSA
25
Hussman Strategic Advisors
Maryland
$5.66M +$2.2M +83,000 +71%

CSII Hedge Fund Activity: Q1 2017 in Review

167 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2017, worth a combined $689M — up 20% from $576M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CSII positions and 12 closed out — a net gain of 32 holders — while 55 added to existing stakes and 50 trimmed.

The largest buyer was BlackRock, adding an estimated $62.4M. The largest seller was Granahan Investment Management, cutting an estimated $21.1M.

  • 167 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2017, up from 142 in Q4 2016.
  • Funds reported $689M of Cardiovascular Systems, Inc. stock for Q1 2017, up 20% quarter-over-quarter.
  • 44 funds opened new Cardiovascular Systems, Inc. positions in Q1 2017 and 12 closed out, a net change of +32 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2017 was BlackRock, an estimated $62.4M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2017 was Granahan Investment Management, an estimated $21.1M sold.

Based on aggregated 13F filings for Q1 2017.